I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
24 mai 2018 13h36 HE
|
I-MED Pharma
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer...
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
24 mai 2018 13h36 HE
|
I-MED Pharma
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution...
I-MED Pharma's I-PEN® Does Not Infringe the TearLab Patent
20 févr. 2018 15h44 HE
|
I-MED Pharma
MONTREAL, Feb. 20, 2018 (GLOBE NEWSWIRE) -- On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent infringement action against I-MED Pharma Inc. in...
I-MED Pharma partners with OCuSOFT to bring the I-PEN® Osmolarity System to the U.S.A.
08 janv. 2018 13h02 HE
|
I-MED Pharma
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-PEN®, I-DROP® et I-PLUG® maintenant offerts en Espagne et au Portugal grâce à un partenariat avec IMEX
08 janv. 2018 09h16 HE
|
I-MED Pharma
MONTRÉAL, 08 janv. 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, a annoncé aujourd’hui la...
I-PEN®, I-DROP® and I-PLUG® now available in Spain and Portugal through Partnership with IMEX
08 janv. 2018 09h16 HE
|
I-MED Pharma
MONTREAL, Jan. 08, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with IMEX...
Dry Eye Syndrome Treatment Market to be worth US$ 6,610 Mn by 2027; Launch of Innovative Products to Drive Growth of Market, Notes FMI
13 déc. 2017 03h56 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
Valley Cottage, New York, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Some of the key players in the global market for dry eye syndrome treatment include names such as Nicox, Candorvision, Novartis, Allergan...
I-PEN®, I-DROP® et I-LID’N LASH® seront offerts au Danemark, en Suède et en Norvège
06 oct. 2017 15h17 HE
|
I-MED Pharma
MONTRÉAL, 06 oct. 2017 (GLOBE NEWSWIRE) -- I-MED Pharma inc., annonce aujourd'hui la nomination de AMWO Farma IVS comme distributeur exclusif du système d'osmolarité lacrymale I-PEN® ainsi que...
I-PEN®, I-DROP® and I-LID’N LASH® will be available in Denmark, Sweden and Norway
06 oct. 2017 15h17 HE
|
I-MED Pharma
MONTREAL, Oct. 06, 2017 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specialized in dry eye diagnosis and management, announced today the appointment of AMWO Farma IVS as its exclusive...
i-Pen® Tear Osmolarity System registered in Japan
19 sept. 2017 14h45 HE
|
I-MED Pharma
MONTREAL, Sept. 19, 2017 (GLOBE NEWSWIRE) -- I-MED Pharma announced today the successful registration of its i-Pen® Tear Osmolarity System (“i-Pen®”) in Japan. The i-Pen® is an in-vivo handheld tear...